LACTATE DEHYDROGENASE (LDH) - ANVISA Registration 10055310844

Access comprehensive regulatory information for LACTATE DEHYDROGENASE (LDH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10055310844 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10055310844
Registration Details
ANVISA Registration Number: 10055310844
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

LACTATE DEHYDROGENASE / LACTATO DESIDROGENASE
Risk Class II

Registration Details

10055310844

250000046729983

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

May 06, 1999

VIGENTE

09/18/2025 19:00:01